Thu.Nov 03, 2022

article thumbnail

Why Digital Health Funding Fell 36% in Q3

MedCity News

During Q3, digital health’s funding fell 36% quarter-over-quarter and 72% from its all-time high during last year’s Q2. The primary driver of this reduction is macro market trends, experts said, though digital health companies need to tie their services more directly to value to get funding in the future.

Marketing 118
article thumbnail

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Medgadget

Medical Microinstruments , a medtech company with offices in Pisa, Italy and Delaware, USA, has developed the Symani Microsurgical Robot. The robotic system is designed to assist with microsurgical procedures, and it boasts a variety of advanced features to achieve this goal. These include a suite of the world’s smallest wristed surgical instruments, tremor reducing technology, and motion scaling (7-20X), to allow surgeons to perform very small and precise movements.

Medical 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Former Mount Sinai Employees Accuse Leadership of Sexism and Ageism

MedCity News

This lawsuit centers on the leadership of the Arnhold Institute for Global Health, which is part of the Icahn School of Medicine, and the hiring decisions made by the school’s dean, Dr. Dennis Charney, as well as alleged discrimination from other leaders.

Medicine 103
article thumbnail

‘Zombie’ cells, Shkreli and cats — new research in toxoplasmosis and how the three are connected

PharmaVoice

Toxoplasmosis is carried by about a third of the world’s population, but effective drugs are lacking — now researchers have discovered a key infection element that could lead to better treatment.

Leads 98
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Hint Health To Offer Expanded Direct Primary Care Platform Through New Acquisition

MedCity News

Hint Health acquired AeroDPC, a software company and electronic medical record for direct primary care clinics. As a result, Hint will release a new product in 2023 that combines tools from both companies.

article thumbnail

GSK preps filing for novel antibiotic for urinary tract infections

pharmaphorum

In an encouraging development for the fight against antimicrobial resistance (AMR), GSK’s novel antibiotic gepotidacin has shown efficacy in two phase 3 trials, setting up regulatory filings. If approved, gepotidacin (GSK2140944) could become the first drug in a new class of oral antibiotics for uncomplicated urinary tract infections (UTIs) in more than 20 years, according to the pharma group, which plans to submit the data to the FDA in the first half of next year.

Pharma 98

More Trending

article thumbnail

Could GSK offer the first RSV older adult vaccine?

European Pharmaceutical Review

GSK has announced the European Medicines Agency (EMA) has validated a marketing authorisation application (MAA) under accelerated assessment for its respiratory syncytial virus (RSV) vaccine for adults above 60. If approved, the vaccine could be the first vaccine to prevent RSV lower respiratory tract disease (LRTD) in older adults. Accelerated assessment?

article thumbnail

How to End the Turf Battles of Senior Care

MedCity News

Let’s tear down the silos that transport seniors through the classic stages of hospitals, rehab, assisted living, and nursing homes. Value-based care or better yet, global risk, has a way of disintegrating these silos. If providers want to get paid, they must collaborate. That means instead of treating a singular issue, we must reach out to the rest of the ecosystem, coordinating treatment and driving together toward a meaningful outcome.

article thumbnail

Magnetic Bacteria Target Tumors

Medgadget

Scientists at ETH Zurich in Switzerland have unveiled a technique that weaponizes bacterial cells against tumors. The approach involves using bacteria called Magnetospirillum that are naturally magnetic by virtue of the iron oxide particles they contain. The researchers use a rotating magnetic field applied at the tumor location from outside the body to help draw the bacteria through gaps in the walls of tumor blood vessels.

article thumbnail

Why Digital Health Collaborations Are the Future of Medtech [Sponsored]

MedCity News

Executives from Huma, Abbott, Smith & Nephew and AliveCor share how they are using real world evidence collection to support remote patient monitoring, maximize patient engagement and navigate the regulatory landscape.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

NGOs claim UK-India free trade deal will raise medicine prices

pharmaphorum

Consumer and health organisations in the UK have written to the Trade Secretary Kemi Badenoch, saying a leaked chapter of the proposed UK-India free trade agreement (FTA) could raise the price of medicines used by the NHS. The non-governmental organisations – which include Oxfam, Medecins sans Frontieres, Global Justice Now and Health Poverty Action, amongst others – are worried about sections of the draft deal dealing with intellectual property.

article thumbnail

Bain Capital-Backed Emalex Bio Lands $250M for Pivotal Test of Tourette Drug

MedCity News

Emalex Biosciences will use the cash from its Series D financing to conduct a Phase 3 clinical trial for ecopipam, an experimental treatment for Tourette syndrome. Though there drugs are already available for Tourette, Emalex’s drug addresses a different central nervous system target that the biotech believes could offer an edge.

article thumbnail

Acumen cruises into the fast lane with novel Alzheimer’s treatment

PharmaVoice

The company’s distinct amyloid-beta target, which just won a fast track designation, could give it an edge over the competition.

article thumbnail

Medical Device Security Startup Reels in $25M as Cyber Threats Escalate

MedCity News

MedCrypt, a San Diego-based provider of cybersecurity solutions for medical devices, recently closed a $25 million Series B funding round. The startup sells its software to medical devices manufacturers so they can enhance the security of their products, which range from pacemakers to CT scanners.

Medical 92
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

The pharmaphorum podcast: Why is digital health so challenging for big tech?

pharmaphorum

In this episode of the pharmaphorum podcast, host Jonah Comstock taps XIL Health’s Susan Lang to better understand why big tech’s ventures into healthcare seem to stumble more often than not. In particular, they dig in on Amazon Care, the much-lauded but recently shuttered employer-based primary care offering. They also touch on Amazon’s other efforts – its successful, but not disruptive acquisition of PillPack and subsequent PBM work, and its failed value-based care joint venture, Haven.

article thumbnail

Valera Health Secures $44.5M To Expand Its Virtual Mental Health Capabilities

MedCity News

The financing round was led by Heritage Group, and included participation from the investment arms of insurers, like Cigna Ventures and Trinnovate Ventures of Blue Cross Blue Shield Arizona. It brings Valera’s total financing amount to about $70 million.

article thumbnail

Seven pharma CEOs unite to achieve emission targets

European Pharmaceutical Review

Seven pharmaceutical CEOs from AstraZeneca, GSK, Merck, Novo Nordisk, Roche, Samsung Biologics and Sanofi have announced joint action to achieve near-term emission reduction targets and fast-track the roll of net zero health systems. This is the first time the global health sector has joined to reduce greenhouse emissions through the Sustainable Markets Initiative (SMI) Health Systems Task Force, a public-private partnership launched at COP26.

Pharma 81
article thumbnail

More Talent and Technology Offer Solutions for Medical Laboratory Staffing Shortages

MedCity News

Process improvement and advanced technology can also help relieve the staffing burden that medical laboratories are facing.

Medical 98
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Live from CPhI: ‘Gut microbiome therapy to be approved in the next two years’

European Pharmaceutical Review

Speaking live from CPhI Frankfurt , Christian Roghi, Director of Microbiome Solutions, predicted microbiome therapy will be the next big breakthrough in novel therapies, rivalling discoveries like mABs, siRNA and CAR T cells. “We are seeing huge interest in microbiome research, especially in the last five years. There have been a large number of publications describing both the science and the potential benefits of a healthy microbiome,” added Roghi.

Safety 81
article thumbnail

Micelle Technology Detects Airborne SARS-CoV-2

Medgadget

At the Pacific Northwest National Laboratory, researchers have developed micelle technology that can detect minute amounts of SARS-CoV-2 in the air. This new capability could provide invaluable monitoring systems to detect viral contamination in healthcare facilities and beyond. Micelles are somewhat similar to liposomes in that they are both like tiny lipid bubbles.

article thumbnail

Global pharma confidence highest on record, shows CPhI Pharma Index

European Pharmaceutical Review

Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. The survey, which offers a collateralised metric of all major categories, acquired data from 400 global pharma companies.

Pharma 79
article thumbnail

Creating Solutions Together at Frankfurt Book Fair 2022

Copyright Clearance Center

The post Creating Solutions Together at Frankfurt Book Fair 2022 appeared first on Copyright Clearance Center.

98
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Anthropy 2022 – Day Two

pharmaphorum

Thursday 3rd November marks the second day of Anthropy 2022 at the Eden Project on the Cornish coast. With pharmaphorum once more in attendance, expect coverage of an ever wide and ranging spectrum of topics, all united by the shared goal of seeking sustainable change for Britain, whilst bearing in mind her role upon the global stage at this critical juncture in history.

article thumbnail

Lhasa and Optibrium improve predictive modelling for drug-metabolising enzymes

PharmaTimes

Research shows how novel predictive models develop drug design and reduce toxicity

95
article thumbnail

How to Integrate Direct-to-Consumer (DTC) Lab Testing into Your Telemedicine Model

Nixon Gwilt Law

A Crash Course on Laboratory Testing in Virtual Care. So you’ve created your multi-jurisdictional telemedicine company , built the platform, capitalized the operation, affiliated with one or more professional corporations that have hired clinicians, and developed care protocols to achieve the highest value virtual care. And now you’re hitting roadblocks.

article thumbnail

Xerion and MDC secure vital brain tumour treatment funding

PharmaTimes

Grant from Innovate UK SMART awarded to accelerate clinical trial progress

96
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

How Pharma, Payers, & Providers are Leveraging Patient Self-Management Platforms

Impetus Digital

Rick Anderson , President of DarioHealth , sat down with me to explore digital therapeutics, how DarioHealth is utilizing AI and behavioral science to personalize each user’s health journey, and how this approach can help improve diversity & inclusion. Here is a sneak peek of our conversation: Q: Maybe we could talk a little bit about what Dario Health does specifically and if there was any jumping off point that happened when the pandemic occured.

article thumbnail

Traditional Training vs. AI-Powered Sales Coaching Platforms 

Quantified

A sales team is the heart of the revenue engine for any business, but only a well-trained sales team can provide the level of growth your organization needs. G2 puts the importance of sales training in much starker terms: “Effective sales coaching can improve win rates by as much as 29%. If your sales reps don’t feel they are learning and growing in your organization, you risk losing upwards of 60% of your entire workforce within four years.” But how do you get there?

article thumbnail

Emalex raises $250m for Tourette syndrome drug development

Pharmaceutical Technology

Emalex Biosciences has raised Series D funds worth $250m led by Bain Capital Life Sciences to progress the development of an investigational new drug for Tourette syndrome. Paragon Biosciences, Valor Equity Partners, Fidelity Management & Research Company and various family offices took part in the financing round. The funding will be used for the Phase III clinical trial and potential marketing of the investigational compound, ecopipam, for treating Tourette syndrome patients.

article thumbnail

8 Ways AI Can Make Your Sales Team Sell Better

Quantified

Over the past few years, artificial intelligence’s power has radically transformed how many business processes are approached. AI has been a boon to companies of all sizes, from automation to greater insights. AI technology has been changing the face of sales departments for years. And now, the ability to improve sales training has an AI solution.

Sales 52
article thumbnail

Clinical Supply Strategies for CROs

When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and ability to hit key milestones such as FPI for their client.